Lifeline Skin Care's parent company, International Stem Cell Corporation (ISCO), is the world leader in human, non-embryonic stem cell research to study diseases and find cures. ISCO is the first company to create human stem cell extracts from unfertilized eggs. Uniquely, ISCO is one of the only U.S.-based stem cell research labs that accepts no government funding. ISCO relies on revenue from its subsidiaries, such as Lifeline Skin Care, to help fund the very important research that we hope will cure serious diseases.
ISCO works together with some of the leading stem cell research centers and institutes to develop and commercialize stem cell technologies. Its research is backed by such reputable partners as: Novocell Inc.(San Diego), University of California San Francisco, University of California Irvine, University of Wurzburg (Germany), and the Scripps Research Institute (California). This company is going where no other company has -- developing ethical, potent human stem cells that will be used to regenerate and repair damaged and diseased tissue.
We are working on Cures for Parkinson's Disease, Liver Damage, Blindness, and More.
ISCO scientists are focused on using human, non-embryonic stem cells to treat severe diseases of the eye, the nervous system, and the liver, where cell therapy has been proven clinically, yet is limited by the availability of safe immune-matched human cells. Their therapeutic programs include:
- Brain -- the search for a cure for Parkinson's Disease
- Liver -- research on curing liver damage
- Corneas -- producing cornea tissue implants
- Stem Cell Bank
International Stem Cell Corporation is a publicly-traded company headquartered in Carlsbad, California. The company's laboratories are in Oceanside, California.